AI ASSISTANT
Ask DrugCentral
Explore drug information in your own words.
Type a question in the search bar above to get started. Each question is answered independently.
AI can make mistakes. Verify answers against the original sources before relying on them.
thonzylamine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 2642 | 91-85-0 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
major descriptor (72-84); file-maintained to PYRIMIDINES
|
Drug dosage:
None
ADMET properties:
None
Predicted pharmacokinetic/toxicological properties (PK-AZ):
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| azlogd74 | LogD at pH 7.4 | 1.258 | Moderate | 0.79 | |
| caco2-efflux | Caco-2 efflux ratio (BA/AB) | 0.386 | Moderate | 0.79 | |
| caco2-intrinsic-papp | Caco-2 intrinsic apparent permeability | 29.242 | 10^-6 cm/s | Moderate | 0.79 |
| dh-clint | Dog hepatocyte intrinsic clearance | 112.202 | uL/min/10^6 cells | Moderate | 0.79 |
| dppb | Dog plasma protein binding (% unbound) | 58.610 | % | Moderate | 0.79 |
| fcs-ppb | Fetal calf serum protein binding (% unbound) | 71.670 | % | Moderate | 0.79 |
| herg | hERG pIC50 | 5.419 | pIC50 | Moderate | 0.79 |
| hh-clint | Human hepatocyte intrinsic clearance | 13.964 | uL/min/10^6 cells | Moderate | 0.79 |
| hlm-clint | Human liver microsomal intrinsic clearance | 14.791 | uL/min/mg protein | Moderate | 0.79 |
| hppb | Human plasma protein binding (% unbound) | 58.490 | % | Moderate | 0.79 |
| kinase-safety-class | ACVR2A,ACVR2B,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK5,CDK9,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,ITK,JAK2,MAP3K21,MAP3K7,MAPK12,MAPK7,MAPK9,MAPKAPK2,NTRK2,PDK2,PDK4,PIK3CB,PIM2,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TGFBR1 | 36 | |||
| kinase-selectivity-class | AXL,BRAF,ERBB2 | 3 | |||
| mdck-mdr1-efflux | MDCK-MDR1 efflux ratio | 0.267 | Moderate | 0.79 | |
| mh-clint | Mouse hepatocyte intrinsic clearance | 208.449 | Moderate | 0.79 | |
| mppb | Mouse plasma protein binding (% unbound) | 61.910 | Moderate | 0.79 | |
| nih-mdck-mdr1-efflux | NIH MDCK-MDR1 efflux ratio | 0.815 | Moderate | 0.79 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| pppb | Pig plasma protein binding (% unbound) | 79.020 | % | Moderate | 0.79 |
| rh-clint | Rat hepatocyte intrinsic clearance | 175.388 | uL/min/10^6 cells | Moderate | 0.79 |
| rh-fuinc | Rat hepatocyte fraction unbound in incubation | 80.360 | % | Moderate | 0.79 |
| rppb | Rat plasma protein binding (% unbound) | 62.560 | % | Moderate | 0.79 |
| solubility-dd | Solubility at pH 7.4 in DMSO | 981.748 | uM | Moderate | 0.79 |
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | D04AA01 | DERMATOLOGICALS ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. Antihistamines for topical use |
| ATC | R01AC06 | RESPIRATORY SYSTEM NASAL PREPARATIONS DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE Antiallergic agents, excl. corticosteroids |
| ATC | R06AC06 | RESPIRATORY SYSTEM ANTIHISTAMINES FOR SYSTEMIC USE ANTIHISTAMINES FOR SYSTEMIC USE Substituted ethylene diamines |
| MeSH PA | D006633 | Histamine Antagonists |
| MeSH PA | D018377 | Neurotransmitter Agents |
| MeSH PA | D018494 | Histamine Agents |
Related Drugs by ATC class:
D04AA Antihistamines for topical use 13 drugs
R01AC Antiallergic agents, excl. corticosteroids 7 drugs
R06AC Substituted ethylene diamines 5 drugs
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 7.8 | Basic |
| pKa2 | 1.88 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| D08587 | KEGG_DRUG |
| C0175162 | UMLSCUI |
| CHEBI:104017 | CHEBI |
| CHEMBL1623738 | ChEMBL_ID |
| DB11235 | DRUGBANK_ID |
| C100145 | MESH_SUPPLEMENTAL_RECORD_UI |
| 5457 | PUBCHEM_CID |
| 4200 | INN_ID |
| R79646H5Z8 | UNII |
| 1360721 | RXNORM |
| d08090 | MMSL |
| 004792 | NDDF |
| 363553005 | SNOMEDCT_US |
Pharmaceutical products:
None